SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,662,000 | +11.0% | 130,472 | +0.1% | 0.01% | +14.3% |
| Q3 2016 | $6,002,000 | +80.9% | 130,334 | +18.4% | 0.01% | +75.0% |
| Q2 2016 | $3,317,000 | +67.5% | 110,084 | +78.3% | 0.00% | +33.3% |
| Q1 2016 | $1,980,000 | -36.7% | 61,752 | +15.2% | 0.00% | -25.0% |
| Q4 2015 | $3,126,000 | +37.6% | 53,624 | -0.1% | 0.00% | +33.3% |
| Q3 2015 | $2,271,000 | -46.0% | 53,671 | -6.9% | 0.00% | -40.0% |
| Q2 2015 | $4,207,000 | +338.2% | 57,631 | +201.6% | 0.01% | +400.0% |
| Q1 2015 | $960,000 | +40.6% | 19,110 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $683,000 | +24.2% | 18,663 | +6.9% | 0.00% | 0.0% |
| Q3 2014 | $550,000 | – | 17,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |